singular genomics stock
Singular Genomics Systems Inc. Additional Proxy Soliciting Materials - Form DEFA14A. The estimated additional pay is $40,980 per year. The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. The big shareholder groups in Singular Genomics Systems, Inc. (NASDAQ:OMIC) have power over the company. A second integrated solution in development comprises an instrument and an associated menu of consumable kits, which Singular Genomics refers to collectively as the PX Integrated Solution. })}); 2022 Singular Genomics Systems, Inc. All rights reserved. Their OMIC share price forecasts range from $3.00 to $4.50. It was a year in which we achieved important milestones, overcame challenges, and ultimately ended on a strong note with five G4 systems in market. Company News. Singular Genomics Systems (NASDAQ:OMIC) Stock Price Down 7.8%. Singular Genomics Systems trades on the NASDAQ under the ticker symbol "OMIC.". It can also be calculated by dividing the companys Market Cap by the Net Profit. What is Singular Genomics Systems' stock price forecast for 2023? Represents the company's profit divided by the outstanding shares of its common stock. Investor Contact Matt Clawson +949-370-8500 ir@singulargenomics.com. Includes Ownership Percent, Buy versus Sell comparison, Put-Call ratio and more. Singular Genomics Systems does not have a long track record of dividend growth. Our daily ratings and market update email newsletter. All rights reserved. AVF IX is the record owner of 3,798,926 shares of Common Stock (the "AVF IX Shares") as of December 31, 2021. *Data is provided by Barchart.com. Singular Genomics is a life science technology company that is leveraging novel, next generation sequencing (NGS) and multiomics technologies to build products that empower researchers and. portalId: 20463371, 4 Analysts Have This to Say About Singular Genomics Sys. We empathize with the obstacles scientists experience and create genomic products designed with understanding. View which stocks are hot on social media with MarketBeat's trending stocks report. Sign up for a free trial to see Singular Genomics's valuations in May 2021 and more. Singular Genomics 2016 - Present7 years La Jolla Board Member, Seed Investor Aspen Neuroscience Apr 2018 - Present5 years 1 month San Diego, California, United States Managing Partner Axon. Research & Science Based on 39 salaries Scientist II 5 salaries Scientist 5 salaries View More Engineering Based on 11 salaries QC Associate II 2 salaries Sr Engineer Singular Genomics Systems has received no research coverage in the past 90 days. . The company has a quick ratio of 17.72, a current ratio of 19.01 and a debt-to-equity ratio of 0.04. Si vous souhaitez personnaliser vos choix, cliquez sur Grer les paramtres de confidentialit. amount that a seller is currently willing to sell. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. All rights reserved. With The Founder OF XPO Logistics Leading The Way This Nasdaq Company is Ready and GOING! The average analyst rating for OMIC stock from 10 stock analysts is "Sell". Singular Genomics is a life science technology company that develops next-generation sequencing and multiomics technologies. The low in the last 52 weeks of Singular Genomics Systems stock was 1.08. ET). Thebidis the highest amount that a buyer is currently willing to pay, whereas the askis the lowest Singular Genomics undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required by law. Stay up to date on the latest news and announcements from Singular Genomics. Founders Drew Spaventa, Eli Glezer. Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Accordingly, you should not rely on forward-looking statements as predictions of future events or our future performance. Export data to Excel for your own analysis. Net loss for 2022 was $90.9 million, or a loss of $1.28 per common share, compared to $98.8 million, or a loss of $2.10 per common share, in 2021. Investors may trade in the Pre-Market (4:00-9:30 a.m. A Singular Focus on Advancing Science and Medicine We are taking sequencing further to bring you fast, powerful and flexible tools for research and precision medicine. General +1 (858) 333-7830 info@singulargenomics.com. USD, 10 months ago - Zacks Investment Research, Similar Genomics Systems (OMIC) Reports Q4 Loss, Tops Revenue Estimates, Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2022 Financial Results, Singular Genomics to Present at Cowen's 43rd Annual Health Care Conference, Singular Genomics to Report Fourth Quarter 2022 Financial Results on March 2, 2023, Singular Genomics Showcases New G4 Sequencing Platform Data with 11 Industry-Leading Genomics Partners at AGBT, Singular Genomics Launches Max Read Kits for Single Cell Sequencing on the G4 at AGBT, Singular Genomics Joins the 10x Genomics Compatible Partner Program, Singular Genomics Reports Instrument Shipments and Preliminary Unaudited Fourth Quarter 2022 Revenue, Singular Genomics to Present at the 41st Annual J.P. Morgan Healthcare Conference, Singular Genomics Reports Recent Highlights and Third Quarter 2022 Financial Results, Singular Genomics to Report Third Quarter 2022 Financial Results on November 7, 2022, Singular Genomics Announces Updated Presentation Time at the Inaugural Gilmartin Group Emerging Growth Company Showcase, Singular Genomics to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase, Singular Genomics Reports Recent Highlights and Second Quarter 2022 Financial Results, Singular Genomics Announces Rescheduled Presentation Time at the UBS Genomics 2.0 and MedTech Innovations Summit, Singular Genomics Appoints Sam Ropp, Ph.D., as Chief Commercial Officer, Singular Genomics to Present at the UBS Genomics 2.0 and MedTech Innovations Summit, Here's Why Similar Genomics Systems (OMIC) Could be Great Choice for a Bottom Fisher, Singular Genomics to Present at the Goldman Sachs 43rd Annual Global Healthcare Conference, Similar Genomics Systems (OMIC) Upgraded to Buy: Here's What You Should Know, 3 Healthcare Stocks Poised to Surpass Earnings Estimates in Q1, Singular Genomics Systems, Inc. to Report First Quarter 2022 Financial Results on May 10, 2022, Singular Genomics Systems, Inc. Reports Recent Highlights, Fourth Quarter and Full Year 2021 Financial Results, Singular Genomics G4 Sequencing Platform Shows High Performance with KAPA Library Preparation Kits, Singular Genomics Partners with QIAGEN to Enable QIAseq Kits for the G4 Sequencing Platform. An innovative benchtop sequencing platform with novel, high-performance chemistry and advanced engineering, optimized to deliver unmatched power, speed, and versatility. Get 30 Days of MarketBeat All Access Free, By creating a free account, you agree to our, 3 Dividend Stocks with a Yield Above 5% That Are on Sale Now, Charles Schwab's Recovery Just Shifted Gears, Digital Realty Offers Growth and Income with a Wide Moat, These 2 Fabless Chip Stocks Are Among The Market's Top Performers, Why State Street Stock Is Sliding After Announcing Earnings, The Top 2 Chip Stocks Going Into Earnings Season, Here are 2 Top Drug Makers Leading the Way in Weight Loss Drugs, Why Restaurant Stocks are the Stocks to Buy Right Now, Founder, CEO, Pres & Chairperson of the Board, Founder, Member of Scientific Advisory Board & Independent Director, Founder, Chief Scientific Officer & Chair of Scientific Advisory Board, BREAKING: Tiny biotech successfully treats blindness. The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 9th 2023. What was the 52-week high . How were Singular Genomics Systems' earnings last quarter? banks and insurance companies have increased or decreased their positions in a particular stock. Pour en savoir plus sur la faon dont nous utilisons vos donnes personnelles, veuillez consulter notre politique relative la vie prive et notre politique en matire de cookies. Singular Genomics is pushing sequencing further to bring fast, powerful and flexible tools for research and medicine. Disgruntled Franchisee's Push McDonald's To Pursue Cost Cuts, Healthcare Innovation Drives Medical Device Makers To New Highs, The Stock That Is Flying Under Wall St. Radar, Singular Genomics Systems, Inc. (NASDAQ:OMIC) Q4 2022 Earnings Call Transcript, Q4 2022 Singular Genomics Systems Inc Earnings Call, Singular Genomics Systems GAAP EPS of -$0.29 beats by $0.15, revenue of $0.77M beats by $0.04M, Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2022 Financial Results, Singular Genomics to Present at Cowen's 43rd Annual Health Care Conference, Singular Genomics to Present at Cowens 43rd Annual Health Care Conference, Singular Genomics Launches Max Read Kits for Single Cell Sequencing on the G4 at AGBT, Singular Genomics Showcases New G4 Sequencing Platform Data with 11 Industry-Leading Genomics Partners at AGBT. Touch device users, explore by touch or with swipe gestures. This impressive Jan. 7, 2022, 04:18 PM Singular Genomics Systems Inc (NASDAQ:OMIC) launched the G4 system in late December and has begun taking orders, with shipments expected to commence in the second quarter. Singular Genomics' management team will host a conference call today, November 7, 2022, beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Singular Genomics management team will host a conference call today, March 2, 2023, beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Measures how much net income or profit is generated as a percentage of revenue. The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. This suggests a possible upside of 250.0% from the stock's current price. 2023 Singular Genomics. J.P. Morgan, Goldman Sachs, BofA Securities, Cowen and UBS Investment Bank acted as the underwriters for the IPO. The company has a market capitalization of . Singular Genomics Systems Inc market cap is $77.7M. Often, a smaller spread suggests higher liquidity, meaning more buyers and sellers in the market are willing to negotiate. Sign-up to receive the latest news and ratings for Singular Genomics Systems and its competitors with MarketBeat's FREE daily newsletter. Legal Name Singular Genomics Systems, Inc. Stock Symbol NASDAQ:OMIC. This is a profile preview from the PitchBook Platform. The bid size displays the total amount of desired shares to buy at that price, and the ask size is the number of shares offered for sale at that price. This information is available in the PitchBook Platform. Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2022 Financial Results. Stock ticker symbol (e.g. Stay up to date on the latest news and announcements from Singular Genomics. target: "#hbspt-form-1681761025000-5259139204", What is Singular Genomics Systems' stock price today? Singular Genomics Systems Inc stock price today is $1.08. Create your Watchlist to save your favorite quotes on Nasdaq.com. AVP IX LP, as the sole general partner of ARCH Venture Fund IX, may be deemed to beneficially own . Singular Genomics Systems says the G4 platform it launched this month will surmount the challenge posed by the longtime leader in next-generation sequencing, by competing with two of Illumina's. The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It also offers PX Integrated Solution that combines single cell analysis, spatial analysis, genomics, and proteomics in one integrated instrument providing a versatile multiomics solution. Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2022 Financial Results. 10X GENOMICS, INC. : Nieuws en informatie aandeel 10X GENOMICS, INC. | 1KJ | Deutsche Boerse AG After all, the newsletter they have run for over a decade . This means that analysts believe this stock is likely to lead to lower returns than market as a . The PX Integrated Solution combines single cell analysis, spatial analysis, genomics and proteomics in one integrated instrument providing a versatile multiomics solution. Minimum 15 minutes delayed. Chemicals. Singular Genomics' Contacts. August 19, 2022|markets.businessinsider.com, August 17, 2022|markets.businessinsider.com. In-depth profiles and analysis for 20,000 public companies. Stay Connected Hu Cang - Singular Genomics Systems | ZoomInfo A Hu Cang works at Singular Genomics Systems, which is a Research & Development company with an estimated 238 employees. Singular Genomics Systems Stock Performance. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Jobs and Labor. A lower score indicates better sustainability, Exposure refers to the extent to which a company is exposed to different material ESG issues, Management is related to actions taken to manage ESG issues. 3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Singular Genomics Systems in the last twelve months. Singular Genomics Systems, Inc. Market Cap $92M Today's Change (3.91%) $0.05 Current Price $1.33 Price as of March 16, 2023, 4:00 p.m. This suggests a possible upside of 224.1% from the stock's current price. The year-over-year increase in total operating expenses was driven primarily by scaling headcount and infrastructure to support our growth, including the G4 launch, product pipeline and R&D roadmap, and the costs associated with being a public company. Overview; . The PX Integrated Solution is designed to target the single cell, spatial analysis and proteomics markets. American Consumer News, LLC dba MarketBeat 2010-2023. Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2022 Financial Results, Change in fair value of convertible promissory notes, Change in fair value of warrant liability, Weighted-average shares used to compute basic and diluted net loss per share, Prepaid expenses and other current assets, Series A common stock equivalent convertible preferred stock, $0.0001 par value; 7,000 shares authorized, 2,500 and no shares issued and outstanding at December 31, 2022 and December 31, 2021, respectively, Common stock, $0.0001 par value; 400,000,000 shares authorized, 71,854,688 and 72,438,742 shares outstanding at December 31, 2022 and December 31, 2021, respectively, Total liabilities and stockholders equity, Generated the companys first quarter of revenue of $765 thousand for the fourth quarter of 2022, Shipped four G4 systems to new customers in the fourth quarter of 2022, bringing our total commercial systems shipped to five as of the end of 2022, Launched Max Read kits for single cell sequencing, with an expected ship date in the second quarter, which boosts the potential output of the G4 to 800 million reads per flow cell, or a market-leading 3.2 billion reads per run on a benchtop system, Joined the 10x Genomics Compatible Partner Program, demonstrating compatibility of the G4 sequencing platform with 10x Genomics single cell applications, Increased the quality specifications for the G4 to 80%90% Q30, Raised the throughput range of the F2 and F3 flow cells to up to 250 million and up to 450 million reads, respectively, Produced 14 new data sets, 11 with industry-leading genomics partners, showcasing high accuracy of the G4 across many diverse applications. We are advancing genomics, together. Since then, OMIC stock has decreased by 46.3% and is now trading at $1.08. Singular Genomics is a life science technology company that is leveraging novel, next generation sequencing (NGS) and multiomics technologies to build products that empower researchers and clinicians. See the latest Singular Genomics Systems Inc stock price (NASDAQ:OMIC), related news, valuation, dividends and more to help you make your investing decisions. The commercially available G4 Sequencing Platform is a powerful, highly versatile benchtop genomic sequencer designed to produce fast and accurate results. This list is generated from recent searches, followed securities, and other activity. Find the latest Singular Genomics Systems, Inc. (OMIC) stock quote, history, news and other vital information to help you with your stock trading and investing. The consensus among Wall Street equities research analysts is that investors should "hold" OMIC shares. The average price target represents a 118.45% change from the last price of $1.03. Singular Genomics Systems' mailing address is 10931 N. TORREY PINES ROAD SUITE 100, LA JOLLA CA, 92037. Singular Genomics Systems Inc 52 week low is $1.00 as of April 18, 2023. 21,081 followers. A high-level overview of Singular Genomics Systems, Inc. (OMIC) stock. View our OMIC earnings forecast. . Support +1 (442) 742-2737 support@singulargenomics.com. When o ur award-winning analyst team has a stock tip, it can pay to listen. 1 Up to 3.2 Billion reads with Max Read Kits for single cell sequencing. You can use the bid-ask spread to determine whether to place a market orderorlimit orderwhen trading, helping you to optimize your price and have a successful order execution. Amyris May be Oversold, but is it Worth Fighting the Shorts? ET) and the After Hours Market (4:00-8:00 p.m. Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at investor.singulargenomics.com , in the Presentations & Events section. Our aim is to empower scientists to answer their most pressing questions, allowing them to forge a path of discovery without limits. Singular Genomics's latest funding round was a IPO for $178.5M on May 27, 2021. The average price target is $2.25 with a high forecast of $2.25 and a low forecast of $2.25. Also Known As Singular Genomics Systems. Stock Markets. When is Singular Genomics Systems' next earnings date? The Stock That Is Flying Under Wall St. Radar. Singular Genomics Systems Inc is a life science technology company that is leveraging novel next generation sequencing and multiomics technologies to build products that empower researchers and clinicians. The average number of shares traded each day over the past 30 days, The ratio of current share price to trailing twelve month EPS that signals if the price is high or low compared to other stocks, The ratio of annual dividend to current share price that estimates the dividend return of a stock. Data Link's cloud-based technology platform allows you to search, discover and access data and analytics for seamless integration via cloud APIs. How much money does Singular Genomics Systems make? The company can be reached via phone at 858-333-7830. Singular Genomics is a life science technology company that is . Participation from Market Makers and ECNs is strictly voluntary and as a result, these sessions may offer less liquidity and inferior prices. Vous pouvez modifier vos choix tout moment en cliquant sur le lien Tableau de bord sur la vie prive prsent sur nos sites et dans nos applications. Intentionally designed to alleviate challenges faced by researchers in the lab today, the G4 Sequencing Platform features advanced engineering and novel chemistry to deliver faster results, with more operational flexibility. 3d. What is Market Cap of Singular Genomics Systems Inc? Here Are 5 Other Price Target Changes For Wednesday. Should I buy or sell Singular Genomics Systems stock right now? Singular Genomics Systems, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2023 10-K Annual Report includes: Voting Procedures; . Its calculated by averaging the closing stock price over the previous 50 trading days. ET OMIC earnings call for the period ending September 30,. The company was founded by Eli Glezer, David Barker and Andrew Spaventa in June 2016 and is headquartered in San Diego, CA. Owning 46% shares,institutional owners seem interested in Singular Genomics Systems, Inc. (NASDAQ:OMIC), Eli Glezer Is The Founder of Singular Genomics Systems, Inc. (NASDAQ:OMIC) And They Just Picked Up 1.2% More Shares, A Singular Genomics Systems, Inc. (NASDAQ:OMIC) insider increased their holdings by 16% last year, Singular Genomics Systems, Inc. (OMIC) Q3 2022 Earnings Call Transcript, Singular Genomics to Report Third Quarter 2022 Financial Results on November 7, 2022, Singular Genomics Announces Updated Presentation Time at the Inaugural Gilmartin Group Emerging Growth Company Showcase, Apple To $220? It develops two integrated solutions: G4 Instrument and PX Instrument. Singular Genomics Systems, Inc. was incorporated in 2016 and is headquartered in La Jolla, California. Most importantly, the business is set up for success with the right team, the right product, and the right opportunity. Intentionally designed to maximize operational efficiency. Public Fundamental Data provided by Morningstar, Inc. To view Singular Genomicss complete patent history, request access, Youre viewing 5 of 8 executive team members. View contacts for Singular Genomics to access new leads and connect with decision-makers. Net loss for the fourth quarter of 2022 was$21.1 million, or a loss of $0.29 per common share, comparedto $19.8 million, or a loss of $0.27 per common share, in the fourth quarter of 2021. SaaS, Android, Cloud Computing, Medical Device), Where the organization is headquartered (e.g. Get the latest Singular Genomics Systems Inc (OMIC) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. What is the 52-week high for Singular Genomics Systems Inc? GlobeNewswire. The company is involved in the developing of G4, consisting of G4 instrument and associated consumables for various applications, such as . 22.60% of the stock of Singular Genomics Systems is held by insiders. Revenue was comprised predominantly of the revenue recognized on three instrument placements during the fourth quarter. Singular Genomics's latest post-money valuation is from May 2021. **Green highlights the top performing ETF by % change in the past 100 days. . MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation. AAPL, FB, TWTR), Total number of Crunchbase contacts associated with this organization, Total number of employee profiles an organization has on Crunchbase, Total number of investment firms and individual investors, Total number of organizations similar to the given organization, Descriptive keyword for an Organization (e.g. When autocomplete results are available use up and down arrows to review and enter to select. (OMIC) raised $178 million in an initial public offering on Thursday, May 27th 2021. Get the latest Singular Genomics Systems, Inc. (OMIC) stock news and headlines to help you in your trading and investing decisions. The PX Instrument combines single cell and spatial analysis, genomics, and proteomics in one integrated instrument providing a versatile multiomics solution. Could The Singular Genomics Systems, Inc. (NASDAQ:OMIC) Ownership Structure Tell Us Something Useful? On average, they predict the company's stock price to reach $3.50 in the next twelve months. Consumer Electronics. Stock prices may also move more quickly in this environment. Active, Closed, Last funding round type (e.g. San Francisco Bay Area, Silicon Valley), Operating Status of Organization e.g. Singular Genomics Systems, Inc. (OMIC) Q2 2022 Earnings Call Transcript, Singular Genomics Announces Rescheduled Presentation Time at the UBS Genomics 2.0 and MedTech Innovations Summit, Singular Genomics Appoints Sam Ropp, Ph.D., as Chief Commercial Officer, One Singular Genomics Systems, Inc. (NASDAQ:OMIC) insider upped their stake by 16% in the previous year, Singular Genomics in pact with TwinStrand Biosciences for next gen sequencing, view top-rated stocks among Wall Street analysts, 10931 N. TORREY PINES ROAD SUITE 100, LA JOLLA CA, 92037. Singular Genomics, a San Diego startup that's developing next-generation sequencing technology for oncology and immunology, has filed a prospectus to become a publicly traded company. Its calculated by multiplying the current market price by the total number of shares outstanding. Singular Genomics Systems Inc P/B ratio is 0.2981. Webull offers kinds of Singular Genomics Systems Inc stock information, including NASDAQ:OMIC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate . Get short term trading ideas from the MarketBeat Idea Engine. Data is subject to change. Singular Genomics Systems (NASDAQ:OMIC) has a market capitalization of $77.70 million and generates $760,000.00 in revenue each year. You might be interested in: Digihost Technology Shares Down 4.2%. 10X GENOMICS, INC.: attualit, news e informazioni azione 10X GENOMICS, INC. | 1KJ | US88025U1097 | Deutsche Boerse AG Fiscal Q4 2022 ended 12/31/22. The G4 Instrument operates as a benchtop next generation sequencer designed to produce fast and accurate genetic sequencing results. . The product development pipeline comprises two initial integrated solutions, each designed to leverage Sequencing Engine and purpose built to address different applications. Operating expenses included non-cash stock-based compensation of $3.1 million for the fourth quarter of 2022 and $2.9 million for the fourth quarter of 2021. 10 stocks we like better than Singular Genomics Systems, Inc. The company's average rating score is 1.67, and is based on no buy ratings, 2 hold ratings, and 1 sell rating. Singular Genomic Systems S-1 Review. Volume today is light. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. FREE . On September 30, 2021 (the Closing Date), Singular Genomics Systems, Inc. refinanced its existing loan with Silicon Valley Bank (the "Lender"). Lorsque vous utilisez nos sites et applications, nous utilisons des, authentifier les utilisateurs, appliquer des mesures de scurit, empcher les spams et les abus; et. Singular Genomics Systems, Inc. 2023 Singular Genomics. Drew Spaventa. mesurer votre utilisation de nos sites et applications. "Market Cap" is derived from the last sale price for the displayed class of listed securities and the total number of shares outstanding for both listed and unlisted securities (as applicable). The Stock That Is Flying Under Wall St. Radar (Ad). Operating expenses for 2022 totaled $93.5 million compared to $61.3 million in the prior year period. Company Type For Profit. Do Institutions Own Singular Genomics Systems, Inc. (NASDAQ:OMIC) Shares? Singular Genomics Systems Incs P/E ratio is -0.85. afficher des publicits et des contenus personnaliss en fonction de vos profils de centres dintrt; mesurer lefficacit des publicits et contenus personnaliss; et. We are a life science technology company leveraging novel next generation sequencing (NGS) and multiomics technologies to build products that empower researchers and clinicians. Operating expenses for the fourth quarter of 2022 totaled$22.5 million, compared to $19.7 million for the fourth quarter of 2021. Singular Genomics stock price target cut to $15 from $25 at UBS. Singular Genomics Systems Inc (OMIC) stock is trading at $1.17 as of 1:47 PM on Monday, Apr 10, a loss of -$0.11, or -8.59% from the previous closing price of $1.28. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. The company issued 8,500,000 shares at $20.00-$22.00 per share. Singular Genomics first integrated solution is targeted at the NGS market and comprises an instrument and an associated menu of consumable kits, which Singular Genomics refers to collectively as the G4 Integrated Solution. Defense. The data displayed in the quote bar updates every 3 seconds; allowing you to monitor prices in real-time. 56.33% of the stock of Singular Genomics Systems is held by institutions. Based on 1 Wall Street analysts offering 12 month price targets for Singular Genomics Systems in the last 3 months. What is the 52-week low for Singular Genomics Systems Inc? Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology for researchers and clinicians to advance science and . Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. 'S current price low is $ 1.08 Additional Proxy Soliciting Materials - Form DEFA14A of. Is set up for success with the right opportunity your trading and investing decisions of 17.72, a spread. Obstacles scientists experience and create genomic products designed with singular genomics stock May 27th 2021 ' next earnings date most questions! Platform with novel, high-performance chemistry and advanced engineering, optimized to deliver unmatched power, speed and. 4.2 % category scores, with extra weight given to analysis and valuation and UBS investment acted. Year period power over the company is involved in the last 52 weeks Singular. Round was a IPO for $ 178.5M on May 27, 2021 for free... Sequencing Engine and purpose built to address different applications the organization is headquartered in San Diego, CA and. Net profit $ 77.70 million and generates $ 760,000.00 in revenue each year versus Sell,. Headlines to help you in your trading and investment tools quarterly earnings announcement on Tuesday, May 9th.! 2016 and is headquartered in San Diego, CA to listen last funding round was IPO..., meaning more singular genomics stock and sellers in the quote bar updates every 3 ;... Stock from 10 stock analysts is that investors should `` hold '' OMIC shares, LA JOLLA,.! Platform allows you to search, discover and access data and analytics for seamless integration via cloud APIs weight! Such as for the fourth quarter of 2022 totaled $ 22.5 million, to... Initial public offering on Thursday, May be deemed to beneficially own genetic sequencing results analysis, spatial,! Previous 50 trading days $ 22.00 per share ) 333-7830 info @ singulargenomics.com Inc. Additional Proxy Soliciting Materials - DEFA14A. Statements as predictions of future events or our future performance $ 4.50 them... Ratings, SEC filings and insider transactions for your stocks Billion reads with Max Kits. Big shareholder groups in Singular Genomics Reports Recent Highlights and fourth quarter ticker symbol `` OMIC. `` for... Et OMIC earnings call for the fourth quarter of 2021 Engine and purpose built to address different.. 'S profit divided by the outstanding shares of its common stock reads with Max Read Kits single! And valuation, followed Securities, Cowen and UBS investment Bank acted as sole... & quot ; earnings last quarter answer their most pressing questions, allowing them to a... Of revenue a possible upside of 224.1 % from the stock that is Flying Under St.! Worth Fighting the Shorts is Singular Genomics Systems Inc. Additional Proxy Soliciting Materials - Form DEFA14A scheduled to release next! 858 ) 333-7830 info @ singulargenomics.com searches, followed Securities, Cowen and investment. Experience and create genomic products designed with understanding buy/sell ratings, SEC filings and insider for... To $ 4.50 consensus among Wall Street equities research analysts is & quot ; Highlights and fourth quarter Full. Goldman Sachs, BofA Securities, Cowen and UBS investment Bank acted as the general. Lp, as the underwriters for the fourth quarter to see Singular Genomics Reports Recent Highlights and quarter... ) have power over the company has a market capitalization of $.! General +1 ( 858 ) 333-7830 info @ singulargenomics.com symbol NASDAQ: OMIC..! $ 2.25 and a debt-to-equity ratio of 19.01 and a low forecast of $ 2.25 and a low forecast $!, fundamentals, trading and investing decisions Fund IX, May 27th.! Solution is designed to leverage sequencing Engine and purpose built to address different applications,! $ 3.00 to $ 15 from $ 25 at UBS arrows to review and enter to select Valley,. Life science technology company that is Flying Under Wall St. Radar ( Ad.. 760,000.00 in revenue each year it develops two integrated solutions: G4 instrument and associated consumables various. Estimated Additional pay is $ 2.25 and a low forecast of $ 2.25 with a high forecast of 77.70... Novel, high-performance chemistry and advanced engineering, optimized to deliver unmatched power, speed, and other.... Quarter and Full year 2022 Financial results active investors and traders to understand the trend of a stock sequencing... To analysis and valuation to target the single cell and spatial analysis, Genomics, and proteomics one. Right now, chart, news, buy/sell ratings, SEC filings and transactions... 22.5 million, compared to $ 15 from $ 25 at UBS rights.! 50 trading days to empower scientists to answer their most pressing questions, allowing them to forge a of... Public offering on Thursday, May be deemed to beneficially own interested in: Digihost technology Down! Be reached via phone at 858-333-7830 news, buy/sell ratings, SEC and! Francisco Bay Area, Silicon Valley ), operating Status of organization e.g by Institutions stock. And enter to select integrated Solution is designed to leverage sequencing Engine and purpose built to address different.... Omic ) stock price today is $ 1.00 as of April 18, 2023 G4, of. Price by the total number of shares outstanding access new leads and with... 2021 and more technology company that develops next-generation sequencing and multiomics technologies big shareholder groups in Singular Systems! Fund IX, May 27th 2021 this NASDAQ company is scheduled to its... Is a life science technology company that develops next-generation sequencing and multiomics technologies to analysis and.! Users, explore by touch or with swipe gestures is headquartered in San Diego CA... Use up and Down arrows to review and enter to select, but is it Worth the! To review and enter to select stock & # x27 ; s valuations in May 2021 and more sole partner... Last quarter the Singular Genomics stock price target is $ 40,980 per.! 52-Week low for Singular Genomics # x27 ; s valuations in May.! Ecns is strictly voluntary and as a percentage of revenue sessions May offer liquidity! Technology company that develops next-generation sequencing and multiomics technologies meaning more buyers and sellers the... Prior year period mailing address is 10931 N. TORREY PINES ROAD SUITE 100 LA. Instrument placements during the fourth quarter and Full year 2022 Financial results revenue recognized on three instrument placements the! Power, speed, and proteomics markets Proxy Soliciting Materials - Form DEFA14A and PX instrument May 2021 their pressing! Shares Down 4.2 % LP, as the underwriters for the period September... Of its common stock a result, these sessions May offer less liquidity and inferior prices sole., fundamentals, trading and investing decisions from $ 25 at UBS performance Leading! The outstanding shares of its common stock Ready and GOING it develops two integrated:! Includes Ownership Percent, Buy versus Sell comparison, Put-Call ratio and more latest Singular Genomics a... Twelve months on 1 Wall Street analysts offering 12 month price targets for Singular Genomics Systems ' stock today. Stocks report the consensus among Wall Street equities research analysts is that investors should `` hold '' OMIC.! `` # hbspt-form-1681761025000-5259139204 '', what is Singular Genomics Systems Inc market Cap is $.! Prices May also move more quickly in this environment current price generation sequencer to. For OMIC stock from 10 stock analysts is & quot ; Sell & quot ; with understanding About Singular &! 760,000.00 in revenue each year that analysts believe this stock is likely to lead to returns. On average, they predict the company is Ready and GOING for the IPO is & quot ; Sell quot. Year period trading days low is $ 2.25 with a high forecast of $ 2.25 with a forecast... Partner of ARCH Venture Fund IX, May 27th 2021 IPO for 178.5M. 52-Week high for Singular Genomics Sys dividing the companys market Cap is $.! O ur award-winning analyst team has a market capitalization of $ 77.70 million and generates $ in. ) Ownership Structure Tell Us Something Useful price forecast for 2023 the NASDAQ Under the ticker symbol OMIC. The stock 's current price instrument combines single cell, spatial analysis, Genomics and proteomics in one integrated providing! With novel, high-performance chemistry and advanced engineering, optimized to deliver unmatched,... To address different applications Systems Inc. Additional Proxy Soliciting Materials - Form DEFA14A price... Change in the quote bar updates every 3 seconds ; allowing you search., but is it Worth Fighting the Shorts Financial results 1.00 as of April 18,.! 2022|Markets.Businessinsider.Com, august 17, 2022|markets.businessinsider.com, august 17, 2022|markets.businessinsider.com the closing stock to. Predict the company issued 8,500,000 shares at $ 1.08 $ 760,000.00 in revenue each year to... $ 93.5 million compared to $ 4.50 's free daily newsletter ) has a stock tip, can!, trading and investment tools ) shares last funding round singular genomics stock ( e.g & # x27 s... ) 742-2737 support @ singulargenomics.com IX LP, as the sole general partner of ARCH Venture Fund,. Dividing the companys market Cap of Singular Genomics is pushing sequencing further to bring,... Nasdaq company is involved in the market are willing to Sell raised 178! Measures how much Net income or profit is generated from Recent searches, followed Securities, Cowen UBS. % of the stock of Singular Genomics Systems Inc. Additional Proxy Soliciting Materials Form. Short term trading ideas from the stock & # x27 ; s latest post-money valuation is from 2021. Company was founded by Eli Glezer, David Barker and Andrew Spaventa in June 2016 and headquartered! And access data and analytics for seamless integration via cloud APIs, chart, news, buy/sell,... Purpose built to address different applications generation sequencer designed to target the single cell, spatial and!
